Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Suzanne I. Anjie"'
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Subcutaneous vedolizumab has demonstrated efficacy as a maintenance therapy in inflammatory bowel disease (IBD). However, data on the extension of subcutaneous vedolizumab injection intervals are lacking. Here, we present the first real-world data on
Externí odkaz:
https://doaj.org/article/cb95d418daec493d8e013e6398779063
Publikováno v:
Clinical Case Reports, Vol 12, Iss 1, Pp n/a-n/a (2024)
Key Clinical Message We present a Crohn's disease patient receiving high dose upadacitinib treatment with elevated CPK levels and myopathy, and provide the reader with practical tips on stopping and restarting upadacitinib, emphasizing the need for a
Externí odkaz:
https://doaj.org/article/66774fa3b7ec4de490f790fddccafb03
Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?
Publikováno v:
Expert Opinion on Biological Therapy. 23:341-351
Introduction: During the last decades, biologics have revolutionized the treatment of Crohn’s disease and ulcerative colitis. Even though the inflammatory bowel disease (IBD) armamentarium is rapidly expanding with novel biologics, anti-tumor necro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5816bbbda6171c4c47869940a88abf2a
https://doi.org/10.1080/14712598.2023.2198086
https://doi.org/10.1080/14712598.2023.2198086
Publikováno v:
Endoscopic Ultrasound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617c8e04f1afb82465b6c98021a6fb1b
https://pubmed.ncbi.nlm.nih.gov/33586694
https://pubmed.ncbi.nlm.nih.gov/33586694